Pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: voluntariness, age 18 - 40 years, regular menstrual cycle varying from 26 to 30 days
Exclusion criteria
Exclusion criteria: pregnancy, lactation, any medication (e. g. hormonal contraceptives, homones, anabolic steroids, analgesic, antidepressants), any pre-existing medical conditions (e.g. diabetes, migraine, multiple sclerosis, psychiatric disorder) or withdrawal of consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Baseline measurement: mechanical pain threshold (with PinPrick; MPT), mechanical pain sensibility (MPS), electrical pain sensibility (EPS), electrical detection threshold (EDT) T0: immediatley after high frequency stimulation (HFS): MPT, MPS, EPS, EDT T1: 1 hour after HFS: MPT, MPS, EPS, EDT T3: three hours after HFS: MPT, MPS, EPS, EDT plus blood sampling T27: 27 hours after HFS: MPT, MPS, EPS, EDT Three measurements: follicular phase, late follicukar phase, luteal phase High levles of progesterone (luteal phase) might amplify an induced primary and/ or secondary hyperalgesia. High levels of estrogen (late follicular phase) might decrease induced hyperalgesia. | — |
Secondary
| Measure | Time frame |
|---|---|
| Measurement for area of hyperalgesia using a brush T0; T1; T3; T27. Regression analysis might detect different gonodal hormones constellations that cause hyperalgesia. | — |
Countries
Germany
Contacts
Klinik für Anästhesiologie, Intensiv-, Palliativ- und Schmerzmedizin; Berufsgenossenschaftliches Universitätsklinikum Bergmannsheil, Bochum